Dr. Melissa Moore, global messenger RNA (mRNA) expert and chief scientific officer of Moderna’s mRNA research platform, joins Dr. Diane Hayes, InCrowd co-founder and board member, for Exploring What Physicians Know and Don’t Know About Nucleic Acid-Based Medicines, a webinar examining the emerging therapy area, medications in the field, and analysis of recent InCrowd prescriber research—Wednesday, October 16, 2019 at 1:00pm ET.

Key learnings:
  • A high-level understanding of the emerging class of therapeutics based on molecular biology approaches to altering gene expression by targeting nucleic acids (DNA and RNA)
  • Prescriber awareness of nucleic acid-based medicines
  • Insight across a variety of specialists from academic medical centers, as well as other practice settings
  • Prescriber perceptions of the potential impact of nucleic acid-based medicines

Who should attend:
  • Anyone interested in nucleic acid-based medicines
  • Healthcare and life science marketers, market insights, research, new business, and commercialization professionals
  • Healthcare and hospital administrators
  • Physicians and biologists interested or involved in nucleic acid-based medicines
  • Payors
  • Pharmacists
  • Those interested in therapeutic innovation

Featured Speakers

Melissa Moore, PhD

Chief Scientific Officer, Platform Research

In her role as Chief Scientific Officer of Moderna’s research platform, Dr. Melissa Moore is responsible for leading mRNA biology, delivery and computation science research at Moderna. She joined Moderna in 2016 from the University of Massachusetts Medical School (UMMS), where she served as Professor of Biochemistry & Molecular Pharmacology, Eleanor Eustis Farrington Chair in Cancer Research and Investigator at the Howard Hughes Medical Institute (HHMI).

Diane Hayes, PhD

Co-Founder & Board Member

Dr. Diane Hayes gravitated to epidemiology while in graduate school, drawn by a love of data. She spent time in academia working on large NIH-sponsored clinical trials, but the bulk of her career has been in the business world. As a co-founder and board member of InCrowd, Dr. Hayes helps to steer the long-term, strategic direction of the company.


Register now for this webinar